So far, Wegovy has only been approved for adults. It may be prescribed in addition to a calorie-reduced diet and more exercise with an initial body mass index of at least 30 kg/m2which is considered obesity (obesity), or in overweight people (BMI 27 bis 30 kg/m2), who also have at least one weight-related comorbidity such as prediabetes, Typ-2-Diabeteshypertension, dyslipidemia, obstructive sleep apnea or cardiovascular disease.
